Abschl. nicht exkl. AM-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines OH-Modells zum WS Epoetin alfa (gentechnisch hergest. humanes Erythropoetin - Einschr. auf Pack. mit Dos. bis 10.000 I.E)
Original notice title
Germany – Pharmaceutical products – Abschl. nicht exkl. AM-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines OH-Modells zum WS Epoetin alfa (gentechnisch hergest. humanes Erythropoetin - Einschr. auf Pack. mit Dos. bis 10.000 I.E)
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
20 / 100
Risk factors
Buyer explicitly states that purchase volumes are unknown and depend on many factors; no minimum quantities are guarant...
Buyer reserves right to terminate the Open-House process early if exclusive agreements are concluded, which typically o...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Jul 2026
- Conclusion of non-exclusive discount agreements for Epoetin alfa (up to 10,000 I.E.)
- Open-House model: all interested pharmaceutical manufacturers can participate if conditions are met
Show full summary
Non-exclusive drug discount agreement (Rabattvereinbarung) under §130a Abs. 8 SGB V for Epoetin alfa (up to 10,000 I.E.) via an Open-House model. The buyer is AOK PLUS (Saxony and Thuringia). The agreement is open to all qualified pharmaceutical manufacturers with no negotiation or exclusivity. No guaranteed volumes; demand-driven. Submission via DTVP portal. First submission deadline: 2024-07-05; contract end: 2026-07-31. Only one lot. Exact value not provided.
Risks
Buyer explicitly states that purchase volumes are unknown and depend on many factors; no minimum quantities are guarant...
Buyer reserves right to terminate the Open-House process early if exclusive agreements are concluded, which typically o...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Administrative
- Submission via DTVP portal after requesting access
- First submission deadline: 05.07.2024; later deadlines as per 'Einreichungsfristen' document
- Late submissions considered for next deadline
Buyer
Name
AOK PLUS - Die Gesundheitskasse für Sachsen und Thürigen
Location
Dresden, DEU
Website
Buyer profile
Identifier
DE256878834
Activity
Health
Lots (1)
LOT-0001
Abschl. nicht exkl. AM-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines OH-Modells zum WS Epoetin alfa (gentechnisch hergest. humanes Erythropoetin - Einschr. auf Pack. mit Dos. bis 10.000 I.E)
Non-exclusive discount agreement for Epoetin alfa (up to 10,000 I.E.) via Open-House model. No exclusivity, no minimum volume. Contract ends 31.07.2026 regardless of signature date.
Location
Duration
Category
Deadline
Award details
Selection criteria
Show original TED data
Original TED description
Siehe Kurzbeschreibung
Procurement Details
- Publication date
- 31 maj 2024
- Notice type
- Contract notice — standard
- Languages
- German
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 322308-2024
Documents (2)
Similar tenders
Estonia – Underwear – Termopesu ostmine
Poland – Hire of industrial vehicles with driver – Kompleksowa obsługa placów składowych i transportu wewnętrznego na powierzchni (w tym kopalnianych sieci kolei wąskotorowych) na rzecz Polskiej Grupy Górniczej S.A. KWK Murcki - Staszic
France – Development services of real estate – SELECTION D'UN PROJET POUR LA REALISATION D'UN ENSEMBLE IMMOBILIER DE 28 LOGEMENTS COLLECTIFS A CHATENAY-MALABRY (92) EN CPI
Poland – Pipeline, piping, pipes, casing, tubing and related items – „Dostawy rur z tworzyw sztucznych dla Południowego Koncernu Węglowego S.A.”
Austria – Construction supervision services – A01 GEN Knoten Linz – Knoten Haid + A01 ASt Traun/Haid - Örtliche Bauaufsicht E&M
Czechia – Diagnostic agents – Dodávky ZP_IVD – Reagencie a spotřební materiál pro sekvenační analýzu
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
20 / 100
Risk factors
Buyer explicitly states that purchase volumes are unknown and depend on many factors; no minimum quantities are guarant...
Buyer reserves right to terminate the Open-House process early if exclusive agreements are concluded, which typically o...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications